2009
DOI: 10.1016/j.bmc.2009.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…In addition, two families of tRNA-dependent transferases, MurMN and FemABX exist to use l -Ala-tRNA Ala as substrates for l -Ala transfer to a peptidoglycan cross-bridge. MurM is involved in the addition of the first amino acids (Ala or Ser) to the cross-bridge, MurN—of the second amino acid (Ala) (62) to lipid intermediate II in peptidoglycan biosynthesis (63). Recently, it was shown that the trans- editing activity of MurM does not require the presence of its second lipid substrate (61) and this protein is able to deacylate not only l -Ala/ l -Ser-tRNA Ala but also l -Ala-tRNA Ser /tRNA Phe /tRNA Lys and Ser-tRNA Phe (64).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, two families of tRNA-dependent transferases, MurMN and FemABX exist to use l -Ala-tRNA Ala as substrates for l -Ala transfer to a peptidoglycan cross-bridge. MurM is involved in the addition of the first amino acids (Ala or Ser) to the cross-bridge, MurN—of the second amino acid (Ala) (62) to lipid intermediate II in peptidoglycan biosynthesis (63). Recently, it was shown that the trans- editing activity of MurM does not require the presence of its second lipid substrate (61) and this protein is able to deacylate not only l -Ala/ l -Ser-tRNA Ala but also l -Ala-tRNA Ser /tRNA Phe /tRNA Lys and Ser-tRNA Phe (64).…”
Section: Discussionmentioning
confidence: 99%
“…From the design of inhibitors targeting ASL region of tRNA [ 213 ] and essential tRNA modification enzymes, to the discovery of new tRNA-dependent inhibition mechanisms against aaRSs, such as those employed by AN2690 [ 80 ] and agrocin 84 [ 109 ], the future for developing tRNA targeting antibiotics looks promising. Finally, tRNAs have been found to play an increasing number of non-canonical roles in microbes and these maybe another rich vein to mine novel drugs and targets [ 169 , 170 ].…”
Section: Discussionmentioning
confidence: 99%
“…Using this approach, an analogue of aminoacyl-tRNA linked to 1, 2, 4 oxazolidine ring has been synthesized that inhibits Fem transferases in Weissella viridescens (FemX Wv (IC 50 = 1.4 μM) [ 169 ]. Similarly, MurM from S. pneumoniae was inhibited by a 2'-deoxyadenosine 3'-phosphonate analogue [ 170 ].…”
Section: Antibiotics Affecting Non-canonical Roles Of Trnamentioning
confidence: 99%
“…Figure 4 highlights differences in tRNAs used in peptidoglycan synthesis versus isoacceptors used in translation. Inhibitors are being developed by the synthesis of stable tRNA analogs, 2′‐deoxy‐adenosine, adenosine 3′‐phosphate analogs, and aryl sulfanilamides, all of which mimic the tetrahedral transition state thought to be part of the MurM catalyzed reaction 133–136…”
Section: Building Bridges: Role Of Aa‐trna In Peptidoglycan Linkagesmentioning
confidence: 99%